돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 29105생성일: 2026년 10월 25일

Dimethylformamide → Dimethyl-[2-(5-phenylethynyl-thiophen-2-yl)-imidazo[1,2-a]pyrazin-3-yl]-amine

https://huagongshe.com/reaction/29105

반응식

참여 물질

역할이름HCID투입량
반응물DimethylformamideHCID 6228—
반응물Methyl iodideHCID 6328—
반응물Ethyl AcetateHCID 8857—
반응물Sodium hydrideHCID 24758—
반응물2-(5-Phenylethynyl-thiophen-2-yl)-imidazo[1,2-a]pyrazin-3-ylamine hydrochlorideHCID 69319360—
생성물Dimethyl-[2-(5-phenylethynyl-thiophen-2-yl)-imidazo[1,2-a]pyrazin-3-yl]-amineHCID 6931690440%

반응 단계

790 mg (2.5 mmol) of 2-(5-phenylethynyl-thiophen-2-yl)-imidazo[1,2-a]pyrazin-3-ylamine hydrochloride (Example 83) were dissolved in DMF (8 ml). After addition of 300 mg (7.5 mmol) of sodium hydride (60% dispersion in mineral oil) in portions, the mixture was stirred at RT for 30 min. 0.3 ml (5.0 mmol) of methyl iodide dissolved in DMF (2 ml) was then added dropwise. The reaction solution was stirred at RT for a further 4 h and then quenched with water (20 ml) and extracted with EA (2×50 ml). The combined organic phases were dried over MgSO4, filtered and evaporated under a vacuum. 351 mg (1.0 mmol, 40% of theoretical) of dimethyl-[2-(5-phenylethynyl-thiophen-2-yl)-imidazo[1,2-a]pyrazin-3-yl]-amine were obtained from the group by crystallisation (EA).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07420056B2
출처 데이터셋uspto-grants-2008_09
ORD IDord-50c0cdb68f814427b1b24cf1ab8a756a
출처 메모uspto-grants-2008_09